Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
8.80
+0.02 (0.23%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $46.55 million as of April 29, 2026. Its market cap has increased by 346.92% in one year.
Market Cap
46.55M
Enterprise Value
-8.01M
1-Year Change
346.92%
Ranking
Category
Stock Price
$8.80
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $46.55M, a decrease of -88.52%. That is a compound annual growth rate of -36.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 46.55M | 60.61% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 53.48M |
| Entera Bio | 52.22M |
| Radiopharm Theranostics | 50.96M |
| Telomir Pharmaceuticals | 50.02M |
| Nutriband | 47.53M |
| Xilio Therapeutics | 47.47M |
| Hyperion DeFi | 47.28M |
| Atossa Therapeutics | 46.67M |